Premium
The treatment of phobic anxiety by zimelidine
Author(s) -
Evans L.,
Moore G.
Publication year - 1981
Publication title -
acta psychiatrica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.849
H-Index - 146
eISSN - 1600-0447
pISSN - 0001-690X
DOI - 10.1111/j.1600-0447.1981.tb00737.x
Subject(s) - anxiety , antidepressant , medicine , phobic disorder , anti anxiety agents , psychiatry , anesthesia , psychology
Seven patients who were diagnosed as suffering from phobic anxiety were treated with a new antidepressant which causes relatively selective inhibition of serotonin uptake. This compound, zimelidine, was given for five weeks in doses of up to 300 mg per day. One patient dropped out of the study. Of the remaining six patients all but one made an improvement, which in most cases is thought to have been a drug effect. One patient relapsed some months following treatment and responded again to treatment with zimelidine having failed to respond to other psychotropic drugs.